FVR Suomen rokotetutkimus Oy
- Address
- Piispansilta 11, 02230 Espoo, Finland
Respiratory Infections and Immune System Research
At FVR Suomen rokotetutkimus Oy in Espoo, clinical trials are focused on protecting young children from respiratory tract diseases linked to RSV. This research area combines immune system processes with infection prevention, with the main goal of assessing whether new preventive approaches can reduce illness and improve safety in infants.
- RSV prevention in healthy infants
- Respiratory tract disease outcomes and protection against lower respiratory infections
- Evaluation of treatment effectiveness and overall safety
The site is contributing to research that helps clarify how well a preventive therapy can limit serious RSV-related illness while remaining well tolerated in a pediatric population.
Bacterial Infections and Vaccine Development
Another key focus at this Finnish research site is pneumococcal infection research, centered on bacterial infections and the body’s immune response. The trials are designed to describe the safety and immune activity of a candidate pneumococcal conjugate approach in toddlers, supporting the development of better protection against a common childhood infection.
- Pneumococcal infections in healthy toddlers
- Vaccine safety and immune response assessment
- Testing a new preventive strategy for bacterial disease
These studies reflect a broader effort to improve childhood infection prevention through vaccination research and careful monitoring of tolerability in young participants.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 107 other sites in Finland
Therapeutic Area Benchmark — Finland
Select a therapeutic area to compare against other sites in Finland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Finland
Market Share
Country: Finland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in FVR Suomen rokotetutkimus Oy
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2b/3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-1654 in Healthy Pre-Term and Full-Term Infants | Merck Sharp & Dohme LLC | Phase IV | Not Recruiting | Nov 2022 | Feb 2024 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Pneumococcal Polysaccharide Serotype 3 Conjugated To Crm197 Adsorbed On Aluminium Phosphate | 1 | Unknown | 2023-11-02 | 2023-11-02 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.